A collaboration between Glaxo Smith Kline, the pharmaceuticals giant, company, and Imec aims to create disruptive new solutions for the pharmaceutical sector. The partnership follows a year of explorative collaboration and research leading to promising preliminary results. It will focus on specific R&D and biomanufacturing projects. In R&D, Glaxo and Imec will explore how nanotechnology ...

This story continues at Imec and Glaxo hook up for bio-manufacturing

Or just read more coverage at Electronics Weekly